These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28411306)

  • 1. Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
    Whealon MD; Gahagan JV; Sujatha-Bhaskar S; O'Leary MP; Selleck M; Dumitra S; Lee B; Senthil M; Pigazzi A
    Ann Surg Oncol; 2017 Aug; 24(8):2122-2128. PubMed ID: 28411306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal anastomosis and hyperthermic intraperitoneal chemotherapy: Should we avoid diverting loop ileostomy?
    Brind'Amour A; Pravong V; Sidéris L; Dubé P; De Guerke L; Fortin S; Auclair MH; Trilling B; Tremblay JF
    Eur J Surg Oncol; 2021 Sep; 47(9):2346-2351. PubMed ID: 33637373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
    Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis.
    van Oudheusden TR; Braam HJ; Luyer MD; Wiezer MJ; van Ramshorst B; Nienhuijs SW; de Hingh IH
    Ann Surg Oncol; 2015 Apr; 22(4):1236-42. PubMed ID: 25319584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters.
    Simkens GA; van Oudheusden TR; Braam HJ; Luyer MD; Wiezer MJ; van Ramshorst B; Nienhuijs SW; de Hingh IH
    Ann Surg Oncol; 2016 Jan; 23(1):99-105. PubMed ID: 26148758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic Anastomosis Without Protective Ileostomy is Safe in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Baron E; Gushchin V; King MC; Nikiforchin A; Sardi A
    Ann Surg Oncol; 2020 Dec; 27(13):4931-4940. PubMed ID: 32506191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal anastomosis during cytoreductive radical surgery in patients with peritoneal surface malignancies. Validation of a new technique (without stoma) to prevent anastomosis leakage in more than 1000 procedures.
    Barrios P; Ramos I; Crusellas O; Sabia D; Mompart S; Martín-Baranera M
    Clin Transl Oncol; 2021 Jun; 23(6):1201-1209. PubMed ID: 33393053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of rectum anastomosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    von Breitenbuch P; Piso P; Schlitt HJ
    J Surg Oncol; 2018 Sep; 118(3):551-556. PubMed ID: 30259520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anastomotic leakage after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal cancer.
    Feenstra TM; Verberne CJ; Kok NF; Aalbers AGJ
    Eur J Surg Oncol; 2022 Dec; 48(12):2460-2466. PubMed ID: 36096855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenectomy Increases Postoperative Complications Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Dagbert F; Thievenaz R; Decullier E; Bakrin N; Cotte E; Rousset P; Vaudoyer D; Passot G; Glehen O
    Ann Surg Oncol; 2016 Jun; 23(6):1980-5. PubMed ID: 26913716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.
    Valle SJ; Alzahrani N; Alzahrani S; Traiki TB; Liauw W; Morris DL
    Surg Oncol; 2016 Sep; 25(3):315-20. PubMed ID: 27566038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of Stoma Formation as Part of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Jacoby H; Berger Y; Barda L; Sharif N; Zager Y; Lebedyev A; Gutman M; Hoffman A
    World J Surg; 2018 Jul; 42(7):2036-2042. PubMed ID: 29302727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion.
    Downs-Canner S; Ding Y; Magge DR; Jones H; Ramalingam L; Zureikat A; Holtzman M; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
    Ann Surg Oncol; 2015 May; 22(5):1651-7. PubMed ID: 25348781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anastomotic leakage following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: A clinical cohort study.
    Herzberg J; Acs M; Guraya SY; Schlitt HJ; Honarpisheh H; Strate T; Piso P
    Surg Oncol; 2024 Jun; 54():102080. PubMed ID: 38663060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverting ileostomy in colorectal surgery: when is it necessary?
    Hanna MH; Vinci A; Pigazzi A
    Langenbecks Arch Surg; 2015 Feb; 400(2):145-52. PubMed ID: 25633276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC).
    Chouliaras K; Levine EA; Fino N; Shen P; Votanopoulos KI
    Ann Surg Oncol; 2017 Apr; 24(4):890-897. PubMed ID: 27995450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
    Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
    World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge.
    Bhagwandin SB; Naffouje S; Salti G
    J Surg Oncol; 2015 Mar; 111(3):324-7. PubMed ID: 25557653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis.
    Lee L; Alie-Cusson F; Dubé P; Sideris L
    J Surg Oncol; 2017 Aug; 116(2):236-243. PubMed ID: 28409831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.